Active Ingredient: OXYBUTYNIN CHLORIDE
Proprietary Name: OXYBUTYNIN CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A076644
Product Number: 002
Approval Date: May 10, 2007
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC.
Marketing Status:
Discontinued
Patent and Exclusivity Information